701
Participants
Start Date
May 31, 2008
Primary Completion Date
January 31, 2013
Study Completion Date
August 31, 2016
ThermoDox
Thermally Sensitive Liposomal Doxorubicin 50 mg/m2 Single 30 minute intravenous infusion
5% Dextrose Solution
Single 30 minute intravenous infusion
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Tri-Service General Hospital, Taipei
Chang Gung Memorial Hospital - Keelung, Keelung
Chang Gung Memorial Hospital - Linkou, Linkou District
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Chang-Gung Memorial Hospital - Chiayi Branch, Chiayi City
Chang Gung Memorial Hospital - Kao Shiung, Niaosong
Chinese General Hospital and Medical Center, Santa Cruz
Cardinal Santos Medical Center, San Juan City
St. Luke's Medical Center, Quezon City
The Medical City, Pasig
Mount Sinai School of Medicine, New York
"Azienda Sanitaria Ospedaliera Ordine Mauriziano di Torino Presidio Ospedaliero Umberto I", Torino
King Chulalongkorn Memorial Hospital, Bangkok
Siriraj Hospital, Bangkok
Thammasat University Hospital, Pathum Thani
Geisinger Health System, Wilkes-Barre
Temple University Hospital, Philadelphia
Azienda Ospedaliera San Gerardo, Monza
Ospedale Classificato San Giuseppe, Milano, Milan
Mayo Clinic - Jacksonville, Florida, Jacksonville
Azienda Ospedaliera di Padova, Padua
Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola Malpighi, Bologna
University Of Louisville, Louisville
Cleveland Clinic, Cleveland
Mayo Clinic, Rochester
Azienda Ospedaliero-Univeristaria Pisana, Pisa
University Malaya Medical Centre, Kuala Lumpur
University of Texas Health Science Center, San Antonio
"Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione Pascale di Napoli", Napoli
UCLA, Los Angeles
Songklanagarind Hospital, Hat Yai
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing
Beijing Cancer Hospital, Peking University School of Oncology, Beijing
Beijing You An Hospital, Capital Medical University, Beijing
Beijing You An Hospital,Capital Medical University, Beijing
The First Hospital of Jilin University, Changchun
Shanghai Changhai Hospital, Second Military Medical University, Shanghai
Nanjing Drum Tower Hospital, The Affilitated Hospital of Nanjing University Medical School, Nanjing
The First Affiliated Hospital of Suzhou University, Suzhou
Tianjin Cancer Hospital, Tianjin
Tianjin No. 3 Central Hospital, Tianjin
The First Affiliated Hospital of Zhejiang University, Hangzhou
The 1st Affiliated Hospital, Fujian Medical University, Fuzhou
Southwest Hospital, The First Affiliated Hospital of the Third Military Medical University, Chongqing
Tongji Hospital, Wuhan
Sun Yat-Sen University Cancer Center, Guangzhou
Oncology Center of Nanfang Hospital, Southern Medical University, Guangzhou
Vancouver General Hospital, Vancouver
Queen Mary Hospital, Hong Kong
Soonchunhyang University Bucheon Hospital, Gyeonggi-do
Toronto General Hospital, Toronto
Istituto dei Tumori Regina Elena, Roma
Chiba University Hospital, Chiba
Yamanashi Prefectural Central Hospital, Kofu
Mie University Hospital, Mie
Saiseikai Niigata Daini Hospital, Niigata
Okayama University Hospital, Okayama
Iwate Medical University Hospital, Shiwa
Kyoundo Hospital, Tokyo
The University of Tokyo Hospital, Tokyo
Japanese Red Cross Medical Center, Tokyo
JR Tokyo General Hospital, Tokyo
Kanto Central Hospital, Tokyo
Wakayama Medical University, Wakayama
Yokohama City University Medical Center, Yokohama
Samsung Medical Center, Seoul
Inje University Ilsan Paik Hospital, Gyeonggi-do
Kyungpook National University Hospital, Daegu
Kyungpook National University Hospital, Daegu
Seoul National University Hospital, Seoul
The Catholic University of Korea, Kangnam St.Mary's Hospital, Seoul
Pusan National University Hospital, Busan
Seoul National University Bundang Hospital, Seongnam-si
Yonsei University Severance Hospital, Seoul
Korea University Medical Center Anam Hospital, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Imunon
INDUSTRY